Objective To evaluate the performance of complement depend micro-lymphocytotoxicity assay (CDMA) for the detection of human leucocyte antigen-B27 (HLA-B27).
Early last month, the company finally completed the cutover of the CDMA 1X service and EVDO high-speed data service over EPON and achieved on-site service test results with flying colors.